Skip to main content
. Author manuscript; available in PMC: 2020 Apr 2.
Published in final edited form as: Cell Metab. 2019 Mar 7;29(4):871–885.e5. doi: 10.1016/j.cmet.2019.02.014

Figure 7 |. L1 transcripts and interferon response are elevated in WT aged mice and are rescued by treatment with NRTIs and SIRT6 overexpression.

Figure 7 |

A, L1 transcripts are elevated in tissues of aged (24 month old) animals, and are repressed in aged MOSES mice overexpressing SIRT6.

B, C, Aged tissues show elevated IFN-α/β expression whereas MOSES mice show decreased expression.

Tissues from 4 months and 24 months old BL/6 and 28 months old MOSES animals were analyzed for L1 expression. Young intestine was used as a reference for the other samples after normalization to actin. Statistical significance determined by t-test asterisk indicate p < 0.05.

D, E, F, Treatment with NRTI reduces IFN-α/β and L1 DNA content in 55-week old mice. The data was normalized to actin and WT heart used as a reference. n=5 animals per group, error bars show SEM. Statistical significance was determined by t-test; asterisk indicate p < 0.05.

G, H, MMP3 and IL6 show significant reduction in several tissues of d4T-treated 55-week old mice. The data was normalized to actin and WT heart was used as a reference. n=5 animals per group, Error bars show SEM. Statistical significance was determined by t-test. Asterisks indicate p < 0.05.

I, D4T treatment ameliorates age-related increase in p16 expression in female p16(LUC) reporter mice. n=10 animals per sex per treatment. Statistical significance determined by t-test, asterisk indicate p < 0.05.

J, DNA methylation age estimated with a multi-tissue DNA methylation clock. Analysis is based on 370 out of 435 clock sites. Each group included aged-matched male (n = 3) and female (n = mice. The mean normalized age was 32 weeks for the control (water) group and 23 weeks for the d4T-treated samples. p = 0.046, two-tailed Mann–Whitney U test.

K, Model. L1 activation causes age-related pathologies through induction of DNA damage and a type I interferon response. These pathologies are rescued or attenuated by inhibition of L1 reverse transcriptase with NRTIs.